Zaynich (cefepime hydrochloride, zidebactam)
New molecular entityPriority review
- Region
- 🇺🇸 US
- Active substance
- cefepime hydrochloride, zidebactam
- Company
- Wockhardt Bio Ag
- Status
- Approved
- FDA approval
- Fri 29 May 2026
- Designations
- New molecular entity, Priority review
- Application
- NDA220787
- Official record
- www.accessdata.fda.gov
Regulatory milestones
Fri 29 May 2026🇺🇸 FDA approval
FDA approves Zaynich (cefepime hydrochloride, zidebactam), a new medicine
Wockhardt Bio Ag; NDA220787; New molecular entity, Priority review; powder · source
Follow Zaynich
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.